The Technical Analyst
Nocturne Acquisition [MBTCU]
Exchange: NASDAQ Sector: Financial Services Industry: Shell Companies
Nocturne Acquisition Price, Forecast, Insider, Ratings, Fundamentals & Signals
-5.28% $10.41
America/New_York / 1 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 60.53 mill |
| EPS: | -0.0610 |
| P/E: | -170.66 |
| Earnings Date: | Mar 30, 2023 |
| SharesOutstanding: | 5.81 mill |
| Avg Daily Volume: | 0.0000 mill |
| RATING 2024-04-03 |
|---|
| B- |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -170.66 | sector: PE -18.15 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -170.66 | industry: PE -25.74 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 10.31 - 10.51 ( +/- 1.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2022-01-10 | Wong Ka Lok | Buy | 0 | |
| 2022-01-10 | Mangiacotti Giuseppe | Buy | 0 | |
| 2022-01-10 | Feng Derek | Buy | 0 | |
| 2021-12-16 | Choi Simon | Buy | 0 | |
| 2021-04-14 | Monzon Henry | Buy | 15 000 | Ordinary Shares |
| INSIDER POWER |
|---|
| 0.00 |
| Last 9 transactions |
| Buy: 1 395 000 | Sell: 0 |
Forecast:
01:40 - $10.71
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $10.41 (-5.28% ) |
| Volume | 0.0001 mill |
| Avg. Vol. | 0.0000 mill |
| % of Avg. Vol | 272.73 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MBTCU
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MBTCU
Nocturne Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the disruptive technology market. The company was incorporated in 2020 and is based in Wilmington, Delaware.
Latest Press Releases
2024-03-19 08:31:00 - Press Release
Nocturne Acquisition Corporation Announces Postponement Of Extraordinary General Meeting Date
Santa ana, ca / accesswire / march 19, 2024 / nocturne acquisition corp. (nasdaq:mbtcu) (the "company"), announced today that the board of directors has voted in favor of postponing the meeting date for the extraordinary general meeting that was to be held on march 19, 2024 for shareholders to vote on the proposed business combination with cognos therapeutics, inc. ("cognos"). the extraordinary general meeting will now be held virtually on april 2, 2024 at 9:00 a.m.
2024-02-27 08:31:00 - Press Release
Nocturne Acquisition Corporation Announces Postponement Of Extraordinary General Meeting Date
Santa ana, ca / accesswire / february 27, 2024 / nocturne acquisition corp. (nasdaq:mbtcu) (the "company"), announced today that the board of directors has voted in favor of postponing the meeting date for the extraordinary general meeting that was to be held on february 27, 2024 for shareholders to vote on the proposed business combination with cognos therapeutics, inc. ("cognos"). the extraordinary general meeting will now be held virtually on march 19, 2024 at 9:00 a.m.
2024-02-05 08:31:00 - Press Release
Nocturne Acquisition Corporation Announces Postponement Of Extraordinary General Meeting
Santa ana, ca / accesswire / february 5, 2024 / nocturne acquisition corp. (nasdaq:mbtcu) (the "company"), announced today that the board of directors has voted in favor of a second postponement of the meeting date for the extraordinary general meeting that was to be held on january 30, 2024 for shareholders to vote on the proposed business combination with cognos therapeutics, inc. the extraordinary general meeting that was postponed until february 6, 2024 has been postponed further and will now be held virtually on february 27, 2024 at 9:00 a.m. eastern time.
2024-01-30 08:31:00 - Press Release
Nocturne Acquisition Corporation Announces Postponement Of Extraordinary General Meeting
Santa ana, ca / accesswire / january 30, 2024 / nocturne acquisition corp. (nasdaq:mbtcu) (the "company"), announced today that the board of directors has voted in favor of postponing the meeting date for the extraordinary general meeting that was to be held on january 30, 2024 for shareholders to vote on the proposed business combination with cognos therapeutics, inc. the extraordinary general meeting will now be held virtually on february 6, 2024 at 10:00 a.m. eastern time, and the company plans to continue to solicit proxies from shareholders during the period prior to the extraordinary general meeting.
2023-08-16 08:05:00 - Press Release
Nocturne Acquisition Corporation Announces Filing Of A Registration Statement On Form S-4 In Connection With Its Proposed Business Combination With Cognos
Transaction expected to accelerate the research and advancement of cognos' proprietary and innovative implantable drug delivery pump to improve outcomes for treatment of brain cancers and other neurological diseases wilmington, de / accesswire / august 16, 2023 / nocturne acquisition corporation (nasdaq:mbtc)(nasdaq:mbtcu)(nasdaq:mbtcr) (the "company", "mbtc" or "nocturne"), today announced the submission via edgar, the u.s. securities and exchange commission's ("sec") online portal, for filing of a registration statement on form s-4 (the "registration statement") with the sec, which includes a preliminary proxy statement/prospectus in connection with the proposed business combination (the "business combination") with cognos therapeutics, inc...
Latest News
2021-06-04 16:05:00 - Accesswire
Nocturne Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
LA JOLLA, CA / ACCESSWIRE / June 4, 2021 / Nocturne Acquisition Corporation (NASDAQ:MBTCU) (the "Company") today announced that it has received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the "Form 10-Q") in a timely fashion. The Notice advised the Company that it was not in compliance with Nasdaq's continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1).
2021-04-29 16:01:00 - Accesswire
Nocturne Acquisition Corporation Announces the Separate Trading of its Ordinary Shares and Rights, Commencing May 3, 2021
LA JOLLA, CA / ACCESSWIRE / April 29, 2021 / Nocturne Acquisition Corporation (NASDAQ:MBTCU) (the "Company" or "MBTC") announced that, commencing May 3, 2021, holders of the units sold in the Company's initial public offering of 11,500,000 units, may elect to separately trade shares of the Company's ordinary shares and rights included in the units. The ordinary shares and rights that are separated will trade on the Nasdaq Capital Market under the symbols "MBTC" and "MBTCR," respectively.
2021-04-14 16:25:00 - Accesswire
Nocturne Acquisition Corporation Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering
LA JOLLA, CA / ACCESSWIRE / April 14, 2021 / Nocturne Acquisition Corporation (NASDAQ:MBTCU), the "Company") announced today that the underwriters in its initial public offering, pursuant to the terms of the underwriting agreement, fully exercised their over-allotment option and, on April 14, 2021, closed the purchase of an additional 1,500,000 units in connection with its initial public offering at $10.00 per unit, generating additional gross proceeds of $15,000,000 and bringing the total gross proceeds of the initial public offering to $115,000,000. Each unit consists of one ordinary share and one right to receive one-tenth of one ordinary share upon the consummation of an initial business combination.